Based on an established common pharmacophore of HIV-1 non-nucleoside reverse transcriptase inhibitors (NNTTIs), a series of quinolin-2-one derivatives were synthesized and assayed for their in vitro activities against HIV-1 reverse transcriptase (RT) for the first time. Some of the tested compounds were active against HIV-1 RT. Compounds 4a2 and 4d2 showed inhibitory activities with IC50 values of 0.21 and 0.15 mM, respectively, with a mode of interaction with RT residues of the allosteric pocket similar to that of efavirenz.
基于已确立的HIV-1非核苷类逆转录酶
抑制剂(NNRTI)的共同药效团,首次合成了一系列
喹啉-2-酮衍
生物,并测定了它们对HIV-1逆转录酶(RT)的体外活性。其中一些化合物表现出对抗HIV-1 RT的活性。化合物4a2和4d2显示出抑制活性,其IC50值分别为0.21和0.15 mM,与
依非韦伦相似,它们与RT的别构口袋残基的相互作用方式相似。